e-learning
resources
Munich 2014
Sunday, 07.09.2014
The assessment of comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Breath analysis in relapsing polychondritis using ion mobility spectrometry
A. Usuba, H. Handa, T. Inoue, M. Okamoto, M. Minashita, S. Maddula, J. I. Baumbach, T. Miyazawa (Kawasaki, Japan; Dortmund, Germany)
Source:
International Congress 2014 – The assessment of comorbidities
Session:
The assessment of comorbidities
Session type:
Thematic Poster Session
Number:
986
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Usuba, H. Handa, T. Inoue, M. Okamoto, M. Minashita, S. Maddula, J. I. Baumbach, T. Miyazawa (Kawasaki, Japan; Dortmund, Germany). Breath analysis in relapsing polychondritis using ion mobility spectrometry. Eur Respir J 2014; 44: Suppl. 58, 986
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Related content which might interest you:
The analysis of breath air by laser spectroscopy method for diagnosis of COPD
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Breath analysis by gas chromatography-mass spectrometry can be used to screen for pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016
Breath by Breath Gas Analysis
Source: Research Seminar 2007 - The limits to exercise in COPD: new insights from new methods
Year: 2007
Detection of lung cancer using expired breath analysis by ion mobility spectrometry
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
Discrimination between oral corticosteroid-treated and oral corticosteroid-non-treated severe asthma patients by an electronic nose platform
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Changes in exhaled volatile organic compound profile after breakfast: Implications for protocol development
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Human breath analysis supports the existence of individual phenotypes
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
Differential ion mobility spectrometry for the discrimination of bacteria in vitro
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Relationship between Volatile Organic Compounds (VOCs) in exhaled breath determined by Proton Transfer Reaction Time of Flight Mass Spectrometry (PTR-TOF-MS), clinical characteristics and airway inflammation in COPD
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Development of a method for quantification of phosphatidylcholine in exhaled breath
Source: International Congress 2016 – Airway biomarkers
Year: 2016
The effects of oral care on FeNO measurement in asthmatic patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Double-tracer gas washout in stable asthma and COPD
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Emissions from silicone stent biofilm detected by ion mobility spectrometry
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Longitudinal changes in exhaled breath GC/MS profiles during loss of asthma control by prospective steroid withdrawal
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Impulse oscillometry in COPD: Correlation to spirometry and whole-body plethysmography
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Late Breaking Abstract - Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry demonstrates inhaled drug deposition in transbronchial cryobiopsy samples of patients with Interstitial Lung Disease (ILD)
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019
Measuring exhaled hydrogen sulphide (eH2S) levels in asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Hydrogen sulphide as a biomarker in COPD and asthma
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept